[1] Chen X, Wang S, Cao W. Mesenchymal stem cell-mediated immunomodulation in cell therapy of neurodegen-erative diseases. Cell Immunol. 2018;326:8-14.[2] Daneshmandi S, Karimi MH, Pourfathollah AA. TGF-β1 Transduced Mesenchymal Stem Cells Have Pro-found Modulatory Effects on DCs and T Cells. Iran J Immunol. 2017;14(1):13-23.[3] Papewalis C, Topolar D, Götz B, et al. Mesenchymal stem cells as cellular immunotherapeutics in allogeneic hematopoietic stem cell transplantation. Adv Biochem Eng Biotechnol. 2013;130:131-162.[4] Shi M, Liu ZW, Wang FS. Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol. 2011;164(1):1-8.[5] Prigione I, Benvenuto F, Bocca P, et al. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells. 2009;27(3):693-702.[6] Garnett HM, Harigaya K, Cronkite EP. Characterization of a murine cell-line derived from cultured bone marrow stromal cells. Stem Cells. 1982;2(1):11-23.[7] Allakhverdi Z, Comeau MR, Armant M, et al. Mast Cell-Activated Bone Marrow Mesenchymal Stromal Cells Regulate Proliferation and Lineage Commitment of CD34(+) Progenitor Cells. Front Immunol. 2013;4:461.[8] Li N, Liu N, Zhou J, et al. Inflammatory environment induces gingival tissue-specific mesenchymal stem cells to differentiate towards a pro-fibrotic phenotype. Biol Cell. 2013;105(6):261-275.[9] Rustad KC, Gurtner GC. Mesenchymal Stem Cells Home to Sites of Injury and Inflammation. Adv Wound Care (New Rochelle). 2012; 1(4):147-152.[10] Müller I, Lymperi S, Dazzi F. Mesenchymal stem cell therapy for degenerative inflammatory disorders. Curr Opin Organ Transplant. 2008;13(6):639-644.[11] Rameshwar P, Qiu H, Vatner SF. Stem cells in cardiac repair in an inflammatory microenvironment. Mi-nerva Cardioangiol. 2010;58(1): 127-146.[12] Vishnu P, Paulsen A, Roy V, et al. Lenalidomide Enhances Clonogenic Activity, Proliferation and Erythroid Lineage Commitment of CD34+ Progenitor Cells While It Is Cytotoxic to CD34- Accessory Cells. Ash Meeting & Exposition. 2010; 116(21) :509-510.[13] 阮光萍,姚翔,刘菊芬,等. 人脐带间充质干细胞的作用_细胞移植_免疫调节及充当基因治疗靶细胞[J]. 中国组织工程研究, 2014,18(41): 6714-6718.[14] Bartold PM, Mcculloch CA, Narayanan AS, et al. Tissue engineering: a new paradigm for periodontal re-generation based on molecular and cell biology. Periodontology.2000;24(1):253-269.[15] Intini G. Future approaches in periodontal regeneration: gene therapy, stem cells, and RNA interference. Dent Clin North Am. 2010;54(1): 141-155.[16] Yao S, Pan F, Prpic V, et al. Differentiation of stem cells in the dental follicle. J Dent Res. 2008;87(8):767-771.[17] 金岩.口腔颌面组织胚胎学[M].西安:陕西科学技术出版社,2002.[18] Alongi DJ, Yamaza T, Song Y, et al. Stem/progenitor cells from inflamed human dental pulp retain tissue regeneration potential. Regen Med. 2010;5(4):617-631.[19] Liu N, Shi S, Deng M, et al. High levels of β-catenin signaling reduce osteogenic differentiation of stem cells in inflammatory microenvironments through inhibition of the noncanonical Wnt pathway. J Bone Miner Res. 2011;26(9):2082-2095.[20] 梁媛媛.喉黏膜慢性炎症组织来源的间充质干细胞的生物学行为观察[D]. 西安:第四军医大学, 2013.[21] Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 2001;11(9):372-377.[22] Hla T, Lee MJ, Ancellin N, et al. Lysophospholipids--receptor revelations. Science. 2001;294(5548):1875-1878.[23] Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7(10):803-815.[24] Wei S, Kitaura H, Zhou P, et al. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest. 2005;115(2):282-290.[25] Lipsky PE, van der Heijde DM, St Clair EW, et al. Infliximab and methotrexate in the treatment of rheuma-toid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med. 2000;343(22):1594-1602.[26] Gilbert LC, Rubin J, Nanes MS. The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab. 2005;288(5):E1011-1018.[27] Zhou FH, Foster BK, Zhou XF, et al. TNF-alpha mediates p38 MAP kinase activation and negatively regu-lates bone formation at the injured growth plate in rats. J Bone Miner Res. 2006;21(7):1075-1088.[28] Kitaura H, Sands MS, Aya K, et al. Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. J Immunol. 2004;173(8):4838-4846.[29] Nanes MS. Tumor necrosis factor-alpha: molecular and cellular mechanisms in skeletal pathology. Gene. 2003;321:1-15.[30] Hess K, Ushmorov A, Fiedler J, et al. TNFalpha promotes osteogenic differentiation of human mesenchymal stem cells by triggering the NF-kappaB signaling pathway. Bone. 2009;45(2):367-376.[31] Zhang XY, Yang YJ, Xu PR, et al. The role of β-catenin signaling pathway on proliferation of rats neural stem cells after hyperbaric oxygen therapy in vitro. Cell Mol Neurobiol. 2011;31(1):101-109.[32] Wang Y, Li YP, Paulson C, et al. Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark Ed). 2014;19: 379-407.[33] 李楠.炎症微环境下人牙龈固有层间充质干细胞生物学特性的研究[D]. 西安:第四军医大学, 2011.[34] Harada Y, Nagao S, Nakamura M, et al. Effect of lipopolysaccharide on thymidine salvage as related to macrophage activation. Immunology. 1995;84(2):247-253.[35] Pereira LO, Rubini MR, Silva JR, et al. Comparison of stem cell properties of cells isolated from normal and inflamed dental pulps. Int Endod J. 2012;45(12):1080-1090.[36] 李江.异种基因修饰猪间充质干细胞对人T细胞免疫功能的调节[D].天津:天津医科大学, 2013.[37] Hou C, Peng D, Gao L, et al. Human umbilical cord-derived mesenchymal stem cells protect from hyperoxic lung injury by ameliorating aberrant elastin remodeling in the lung of O2-exposed newborn rat. Biochem Biophys Res Commun. 2018;495(2):1972-1979.[38] 陆晓茜,刘霆,孟文彤,等. 人骨髓间充质干细胞对T淋巴细胞的免疫调节作用[J]. 中国实验血液学杂志, 2005,13(4): 651-655.[39] Fechter K, Dorronsoro A, Jakobsson E, et al. IFNγ Regulates Activated Vδ2+ T Cells through a Feedback Mechanism Mediated by Mesenchymal Stem Cells. PLoS One. 2017;12(1):e0169362.[40] Parekkadan B. Cellular and molecular immunotherapeutics derived from the bone marrow stroma. Massa-chusetts Institute of Technology, 2008.[41] 李建国,颛孙永勋,冉丕鑫,等. 骨髓间充质干细胞对哮喘小鼠CD4+CD25+调节性T细胞及气道炎症的影响[J].中国组织工程研究与临床康复, 2008, 12(47): 9302-9305.[42] Plock JA, Schnider JT, Schweizer R, et al. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplan-tation. Transplantation. 2017;101(1):e1-e11.[43] Valencia J, Blanco B, Yáñez R, et al. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor. Cytotherapy. 2016;18(10):1297-1311.[44] Ding H, Zhang H, Ding H, et al. Transplantation of placenta-derived mesenchymal stem cells reduces hy-poxic-ischemic brain damage in rats by ameliorating the inflammatory response. Cell Mol Immunol. 2017;14(8):693-701.[45] 房佰俊,宋永平,林全德,等. 成年人脂肪源间充质干细胞治疗急性移植物抗宿主病后CD+8 T细胞亚群的变化[J]. 白血病•淋巴瘤, 2006,15(5): 351-352,355.[46] 杜优优,周胜华,周滔,等. 骨髓间充质干细胞移植对心肌梗死后炎性细胞因子表达的调节[J]. 中国组织工程研究与临床康复,2008,12(8): 1440-1444.[47] 刘元林,江小霞,苏永锋,等. 活化的T细胞促进间充质干细胞分化为成骨细胞[J]. 中国实验血液学杂志, 2009,17(4):974-976.[48] 江小霞,张毅,李秀森,等. 间充质干细胞对T淋巴细胞转化的影响[J]. 解放军医学杂志, 2005,30(2): 130-132.[49] Pinheiro CH, de Queiroz JC, Guimarães-Ferreira L, et al. Local injections of adipose-derived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev. 2012;8(2):363-374.[50] Liu D, Xu J, Liu O, et al. Mesenchymal stem cells derived from inflamed periodontal ligaments exhibit im-paired immunomodulation. J Clin Periodontol. 2012;39(12):1174-1182.[51] Matula Z, Németh A, L?rincz P, et al. The Role of Extracellular Vesicle and Tunneling Nanotube-Mediated Intercellular Cross-Talk Between Mesenchymal Stem Cells and Human Peripheral T Cells. Stem Cells Dev. 2016;25(23):1818-1832.[52] Sivanathan KN, Gronthos S, Grey ST, et al. Immunodepletion and Hypoxia Preconditioning of Mouse Com-pact Bone Cells as a Novel Protocol to Isolate Highly Immunosuppressive Mesenchymal Stem Cells. Stem Cells Dev. 2017;26(7):512-527.[53] Luk F, Carreras-Planella L, Korevaar SS, et al. Inflammatory Conditions Dictate the Effect of Mesenchymal Stem or Stromal Cells on B Cell Function. Front Immunol. 2017;8:1042.[54] Chang TC, Yu CC. Mesenchymal stem cells in inflammatory microenvironment promotes cancer cell migra-tion and epithelialmesenchymal transition through osteopontin. Journal of Cancer Science & Therapy. 2017;9(4): 26.[55] Korkaya H, Liu S, Wicha MS. Regulation of cancer stem cells by cytokine networks: attacking cancer's in-flammatory roots. Clin Cancer Res. 2011;17(19):6125-6129.[56] 王晓宇,侯玲玲,马海滨,等.间充质干细胞对免疫细胞的抑制作用及其机制[J].中国生物化学与分子生物学报, 2011, 27(5): 397-402.[57] 王焕丽,熊兵,陈华德,等.骨髓间充质干细胞对巨噬细胞分泌炎症因子的影响[J].南方医科大学学报, 2014, 34(9): 1259-1264.[58] 靳丽媛,邓子辉,张金英,等.间充质干细胞上清对高糖慢性炎症损伤的巨噬细胞表型极化的影响[J].中华老年多器官疾病杂志, 2017, 16(4): 283-287.[59] Hajkova M, Hermankova B, Javorkova E, et al. Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations. Stem Cell Rev. 2017;13(1):104-115.[60] Peng Y, Chen X, Liu Q, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10.Leukemia. 2015;29(3):636-646.[61] Meisel R, Zibert A, Laryea M, et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase- mediated tryptophan degradation. Blood. 2004;103(12):4619-4621.[62] Luk F, de Witte SF, Korevaar SS, et al. Inactivated Mesenchymal Stem Cells Maintain Immunomodulatory Capacity. Stem Cells Dev. 2016; 25(18):1342-1354.[63] Pezato R, de Almeida DC, Bezerra TF, et al. Immunoregulatory effects of bone marrow-derived mesenchy-mal stem cells in the nasal polyp microenvironment. Mediators Inflamm. 2014;2014:583409.[64] Zachar L, Ba?enková D, Rosocha J. Activation, homing, and role of the mesenchymal stem cells in the in-flammatory environment. J Inflamm Res. 2016;9:231-240.[65] Lu H, Wu X, Wang Z, et al. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment. J Surg Res. 2016;205(2):464-473.[66] Franquesa M, Hoogduijn MJ, Bestard O, et al. Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol. 2012;3: 212.[67] Han Z, Tian Z, Lv G, et al. Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J Cell Mol Med. 2011;15(11):2343-2352.[68] Sun Z, Wang S, Zhao RC. The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol. 2014;7:14.[69] 鲁刚,马奎,付小兵,等.脐带间充质干细胞调节炎性微环境干预急性肾损伤的效应研究[J].感染、炎症、修复, 2014,14(2):79-83.[70] Jing Y, Han Z, Liu Y, et al. Mesenchymal stem cells in inflammation microenvironment accelerates hepato-cellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One. 2012;7(8): e43272.[71] Hogan NM, Dwyer RM, Joyce MR, et al. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Int J Cancer. 2012;131(1):1-7.[72] Brennen WN, Denmeade SR, Isaacs JT. Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment. Endocr Relat Cancer. 2013;20(5):R269-290.[73] Liu J, Wang L, Liu W, et al. Dental follicle cells rescue the regenerative capacity of periodontal ligament stem cells in an inflammatory microenvironment. PLoS One. 2014;9(9):e108752.[74] Munir H, Benjamin A, Allwood JW, et al. A1.18 Mesenchymal stem cells lose their immuno-protective ef-fects upon changes in their local microenvironment.Annals of the Rheumatic Diseases.2016;75(Suppl1): A8.1-A8.[75] Buhrmann C, Mobasheri A, Matis U, et al. Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment. Arthritis Res Ther. 2010;12(4):R127.[76] Lerrer S, Liubomirski Y, Bott A, et al. Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells. Front Immunol. 2017;8:479. |